Results

Total Results: 2,919 records

Showing results for "risks".

1. A Multicenter, Observational Cohort Study to Assess the Cardiovascular Risks of Medications Prescribed for Attention Deficit Hyperactivity Disorder | Effective Health Care Program
   effectivehealthcare.ahrq.gov/products/adhd-medicines-risks
   January 01, 2005 - A Multicenter, Observational Cohort Study to Assess the Cardiovascular Risks of Medications Prescribed … Abstract Archived A Multicenter, Observational Cohort Study to Assess the Cardiovascular Risks

2. A Multicenter, Observational Cohort Study to Assess the Cardiovascular Risks of Medications Prescribed for Attention Deficit Hyperactivity Disorder | Effective Health Care (EHC) Program
   effectivehealthcare.ahrq.gov/products/adhd-medicines-risks/abstract
   January 01, 2005 - A Multicenter, Observational Cohort Study to Assess the Cardiovascular Risks of Medications Prescribed … assignment will be designed to: 1) assess the relationship between use of medications for ADHD and the risk … and youth, aged 2-24 years; 2) assess the relationship between use of medications for ADHD and the risk … We will conduct two retrospective cohort studies of the use of medications for ADHD and the risk of serious … for a cohort of individuals, identifying important cardiovascular outcomes, and assessing the overall risk

3. Developing Methods to Assess Health Outcomes in the Presence of Competing Risks for Effectiveness Research | Effective Health Care Program
   effectivehealthcare.ahrq.gov/products/health-outcomes-competing-risks
   February 11, 2010 - Developing Methods to Assess Health Outcomes in the Presence of Competing Risks for Effectiveness Research … Report Developing Methods to Assess Health Outcomes in the Presence of Competing Risks

4. Developing Methods to Assess Health Outcomes in the Presence of Competing Risks for Effectiveness Research | Effective Health Care Program
   effectivehealthcare.ahrq.gov/products/health-outcomes-competing-risks/abstract
   February 11, 2010 - Developing Methods to Assess Health Outcomes in the Presence of Competing Risks for Effectiveness Research … An interval of homogeneity of treatment effect was the interval of the baseline risk of outcome in which … Absolute risk reduction for individuals was estimated for both benefit and harm outcomes and presented … Objectives To demonstrate the importance of considering competing risks in the evaluation of treatment … Research Design and Methods We reviewed 3 statistical approaches for analyzing the competing risks

5. S23 (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/s23.pdf
   October 01, 2007 - and Their Association With Stroke Therapy Relative Risk No. … Again, communication of frequency information rather than relative risks is critical to debate. … Benefits and harms not presented in the same metric (ie, relative risks for benefits and frequencies … For the most part, the articles discuss relative estimates (relative risks or odds ratios; Fig. 1). … Benign breast disease—the risks of commu- nicating risk �comments�.

6. Fagerlin-notes-151007 copy-Teresa (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/fagerlin-presentation.pdf
   November 11, 2015 - F or example, the risks and  benefits across various treatments is not sufficient. … S imilarly, what is a higher risk: one out of ten, hundred, a thousand? … One journal presented   the data about the effectiveness of chemotherapy using relative risks. … Oncologists who got the relative risk information were more likely to say that they would  prescribe … Behaviors are influenced   both   by beliefs and  by the feelings of risks.

7. Topic Suggestion Description | Effective Health Care Program
   effectivehealthcare.ahrq.gov/get-involved/nominated-topics/what-is-the-comparative-effectiveness-of-various-local-treatments-for-1-unresectable-liver-metastases-and-2-unresectable-localized-hepatocellular-carcinoma-hcc-does-the-comparative-effectiveness-vary-when-lesions-are-unresect
   January 07, 2011 - The need to fully understand relative risks and benefits is key in this clinical situation. … Describe any health-related risks, side effects, or harms that you are concerned about. … In studying relative risks and benefits, it will likely be important to factor in the reason a tumor … Patients need to understand the relative benefits and risks of these interventions, whether done as individual

8. A-Z List of Health Topics | Effective Health Care (EHC) Program
   effectivehealthcare.ahrq.gov/health-topics/health-risks-of-an-inactive-lifestyle

9. Pharmacologic and Mechanical Prophylaxis of Venous Thromboembolism Among Special Populations | Effective Health Care (EHC) Program
   effectivehealthcare.ahrq.gov/products/vte-prophyalaxis/research
   May 29, 2013 - underweight patients; those having obesity surgery; or with acute or chronic renal failure have unequal risks … for eligibility, serially abstracted data using standardized forms, and independently evaluated the risk … We qualitatively synthesized the evidence and also pooled the relative risks from the controlled studies … The majority of observational studies had a high risk of bias. … idea that IVC filters with usual care are associated with increased mortality and do not decrease the risk

10. mmeta: Exact Bayesian Inference for Multivariate Meta-analysis of Binary Outcomes | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/mmeta/abstract
    February 11, 2014 - We proposed a novel model for multivariate meta-analysis of binary outcomes where the risks are modeled … specify a link function, and has a closed-form expression of distribution functions for study-specific risk … The exact posterior distributions of the study-specific comparative measures (e.g., odds ratio, relative … risk, risk difference) are derived. … 2 diabetes mellitus due to gestational diabetes mellitus (Chen et al. 2014 CIS-T&M), and comparing risks

11. For the elderly taking cardiovasculare medications, what are the comparative risks and benefits of commonly used herbal supplements. | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/get-involved/nominated-topics/for-the-elderly-taking-cardiovasculare-medications-what-are-the-comparative-risks-and-benefits-of-commonly-used-herbal-supplements
    April 01, 2009 - For the elderly taking cardiovasculare medications, what are the comparative risks and benefits of commonly … Describe any health-related risks, side effects, or harms that you are concerned about. … It should be determined the risks and benefits of these supplements so that clear information can be … Elderly patients are at significant risk for effects on their health and also their limited funds. … more than one category if appropriate) The information will be used to guide patients as to the risks

12. Protocol for Quantitative Assessment of Benefit and Harm analysis of Aspirin for primary prevention (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-balancing-harms-benefits_research.pdf
    February 01, 2014 - risk reductions or relative risk increases of aspirin on benefit and harm outcomes did not change over … Applicability of Effects We assumed RR reductions in benefits or relative risk increases in harms, from … and equal for both groups (i.e. relative risk of 1.0). … risk reduction for MI of about 14 percent9 using the relative risk method. … CI = confidence interval, MI = Myocardial infarction, RR = Relative risk Table A-2.

13. The Effectiveness and Risks of Long-Term Opioid Treatment of Chronic Pain | Effective Health Care Program
    effectivehealthcare.ahrq.gov/products/chronic-pain-opioid-treatment
    December 19, 2013 - The Effectiveness and Risks of Long-Term Opioid Treatment of Chronic Pain Timeline … December 19, 2013 Research Protocol Archived The Effectiveness and Risks … September 29, 2014 Systematic Review Archived The Effectiveness and Risks

14. Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors (ACEIs) and Angiotensin II Receptor Antagonists (ARBs) for Treating Essential Hypertension | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/ace-inhibitor-arb-2007/research-2007-1
    November 01, 2007 - individuals with hypertension regarding their relative benefits (blood pressure control, cardiovascular risk … reduction, cardiovascular events, quality of life, and other outcomes), as well as relative risks (safety

15. Evidence Summary_Models of Care That Include Primary Care for Adult Survivors of Childhood Cancer: A Realist Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/models-care-adult-survivors-childhood-cancer-evidence-summary.pdf
    February 01, 2022 - Summary Main Points Background and Purpose Childhood cancer survivors are at increased risk … literature include oncology care versus primary care, survivor and provider knowledge (e.g., survivor risks … as described by the Stakeholders: “Survivors feel confident about sharing their history, know their risks … access relevant care and services” and “PCPs understand a survivor’s history, know the survivor’s risks … to inform delivery of survivorship-related care Survivors can share their history, know their risks

16. Venous Thromboembolism Prophylaxis in Major Orthopedic Surgery: Systematic Review Update | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/thromboembolism-update/research-2017
    June 22, 2017 - In THR, LMWH has lower VTE and adverse event risks than unfractionated heparin; LMWH and aspirin have … similar risks of VTE and major bleeding; direct thrombin inhibitors (DTI) have lower DVT risk than LMWH … LMWH and aspirin have similar risks of total PE, symptomatic DVT, and major bleeding (low SoE). … Longer duration LMWH has lower risk of various VTE outcome risks (low to high SoE). … In THR, LMWH has lower VTE and adverse event risks than UFH, LMWH and aspirin have similar risks of VTE

17. Topic Suggestion Description | Effective Health Care Program
    effectivehealthcare.ahrq.gov/get-involved/nominated-topics/evidence-based-treatment-for-pressure-ulcers-by-stage
    September 22, 2010 - terms of time to heal or prevention or progession to a worse stage Describe any health-related risks … yet there is no succint clinician guide or other summary of evidence-based interventions and their relative … risks and benefits Potential Impact How will an answer to your research question be used or help … you heard about the Effective Health Care Program AHRQ email newsletter Pressure Ulcer Risk

18. Effectiveness and Safety of Antiepileptic Medications in Patients With Epilepsy | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/epilepsy-medicine/research
    December 21, 2011 - For dichotomous endpoints, we used relative risks, and for continuous endpoints, we used weighted mean … The risk of withdrawing due to adverse events and the risk of several adverse events including fatigue … The risk of withdrawing for any reason was not significantly impacted. … The risks of vomiting and gum hyperplasia were significantly lower for newer antiepileptic medications … However, these adverse events did not significantly increase the risk of withdrawals.

19. Topic Suggestion Description | Effective Health Care Program
    effectivehealthcare.ahrq.gov/get-involved/nominated-topics/31704
    March 01, 2018 - Advising a pregnant or breastfeeding woman to discontinue medication exchanges the fetal or neonatal risks … of medication exposure for the risks of untreated maternal illness. … medications is a cause of concern for physicians and their patients because of the potential teratogenic risk … , the risk of perinatal syndromes or neonatal toxicity, and the risk for abnormal postnatal behavioral … With the limited information available on the risks of the psychotropic medications, clinical management

20. THIS IS OUR TEACHER! (ppt file)
    effectivehealthcare.ahrq.gov/sites/default/files/communicating_risk_media_wilkes.ppt
    April 01, 2006 - , small differences between risks, and uncertainty around risks Public Expectations Public believes … million cases of breast cancer. raloxifene is already used to prevent bone loss after menopause NCI used relative … risk reductions in their promotion rather than absolute risk reductions At the press release and conference … Why are risks minimized? … new possibilities Tools to help patients better understand the health care system and risk